Has Eduardo Braun, MD received payments from drug or device companies?

Yes. Drug and device makers reported $38,561 in general payments to Eduardo Braun, MD across 275 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eduardo Braun, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eduardo Braun, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eduardo Braun, MD

Medical Oncology · Westville, INNPI 1144486309

Payments from drug & device makers

$38,561in general payments, 2019–2025

Across 275 payments — averaging $140.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Genentech USA, Inc.$11K
AstraZeneca$11K
Eisai Inc.$4K
Beigene USA, Inc.$3K
GSK$2K
Bristol Myers Squibb$2K
plus $6K from 49 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Genentech USA, Inc.	23	$10,836
AstraZeneca(2 entities)	22	$10,702
Eisai Inc.	11	$3,606
Beigene USA, Inc.	4	$2,983
GSK	17	$2,384
Bristol Myers Squibb	13	$1,949
Janssen Scientific Affairs, LLC	2	$1,617
E.r. Squibb & Sons, L.L.C.	21	$435
Merck	18	$403
Gilead	17	$377
Johnson & Johnson(2 entities)	8	$355
Astellas Pharma US Inc	10	$239
Sanofi	8	$219
Novartis	10	$211
Pfizer	8	$172
Amgen	7	$128
Daiichi Sankyo Inc.	4	$104
Sobi, Inc	4	$102
AbbVie	5	$100
Tempus AI, Inc	1	$100
Genentech, Inc.	1	$100
Regeneron Healthcare Solutions, Inc.	4	$96
Syndax Pharmaceuticals, Inc.	3	$89
Intuitive Surgical	2	$81
Boehringer Ingelheim	3	$75
Novo Nordisk	1	$69
Exelixis Inc.	3	$64
Iovance Biotherapeutics, Inc.	3	$63
Lilly USA, LLC	3	$61
Incyte Corporation	3	$60
Sumitomo Pharma America, Inc.	2	$53
Adaptive Biotechnologies Corporation	2	$49
Tolmar, Inc.	2	$46
Azurity Pharmaceuticals, Inc.	2	$45
Pharmaessentia USA Corporation	2	$44
ADC Therapeutics America, Inc.	2	$43
Array Biopharma Inc	2	$42
Rigel Pharmaceuticals, Inc.	2	$42
Mirati Therapeutics, Inc.	2	$38
Bayer	2	$36
Seagen Inc.	2	$34
Jazz Pharmaceuticals Inc.	1	$30
Myovant Sciences Inc.	1	$29
Tolmar Pharmaceuticals, Inc.	1	$27
Ipsen Biopharmaceuticals, Inc	1	$27
Stemline Therapeutics Inc.	1	$26
Acrotech Biopharma Inc.	1	$25
Coherus Oncology, Inc.	1	$24
Beone Medicines USA, Inc.	1	$23
Pharmacosmos Therapeutics Inc.	1	$21
Puma Biotechnology, Inc.	1	$21
Fennec Pharmaceuticals, Inc.	1	$21
EMD Serono, Inc.	1	$16
AVEO Pharmaceuticals, Inc.	1	$15
Clovis Oncology, Inc.	1	$3

How this compares

$38,561 in reported general payments places this provider in the 65th percentile of 67 medical oncology providers in Indiana.

See all medical oncology providers in Indiana →

Medicare billing

Part B allowed, 2024

$2,263,587

Medicare patients

349

Services billed

103,532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Westville

Sunil BabuFort Wayne$12.5M
Bert OneilIndianapolis$7.6M
Natraj AmmakkanavarIndianapolis$4.1M
Takefumi KomiyaFort Wayne$2.8M
Nasser HannaIndianapolis$2M
Costantine AlbanyLafayette$1.1M
Bolanle AdepojuGoshen$1M
Vijaya KakaniLafayette$942K
Pablo BedanoIndianapolis$886K
Kelvin LeeIndianapolis$662K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →